GB0127132D0 - Assay - Google Patents

Assay

Info

Publication number
GB0127132D0
GB0127132D0 GBGB0127132.9A GB0127132A GB0127132D0 GB 0127132 D0 GB0127132 D0 GB 0127132D0 GB 0127132 A GB0127132 A GB 0127132A GB 0127132 D0 GB0127132 D0 GB 0127132D0
Authority
GB
United Kingdom
Prior art keywords
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0127132.9A
Other versions
GB2381866A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Karo Pharma AB
Original Assignee
Karo Bio AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karo Bio AB filed Critical Karo Bio AB
Priority to GB0127132A priority Critical patent/GB2381866A/en
Publication of GB0127132D0 publication Critical patent/GB0127132D0/en
Publication of GB2381866A publication Critical patent/GB2381866A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB0127132A 2001-11-12 2001-11-12 Assays for liver X receptor (LXR) modulators Withdrawn GB2381866A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0127132A GB2381866A (en) 2001-11-12 2001-11-12 Assays for liver X receptor (LXR) modulators

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0127132A GB2381866A (en) 2001-11-12 2001-11-12 Assays for liver X receptor (LXR) modulators

Publications (2)

Publication Number Publication Date
GB0127132D0 true GB0127132D0 (en) 2002-01-02
GB2381866A GB2381866A (en) 2003-05-14

Family

ID=9925618

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0127132A Withdrawn GB2381866A (en) 2001-11-12 2001-11-12 Assays for liver X receptor (LXR) modulators

Country Status (1)

Country Link
GB (1) GB2381866A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023240376A1 (en) * 2022-06-12 2023-12-21 中国医学科学院药物研究所 Use of intestinal epithelial cell nuclear receptor repressor ncor as target in drug screening

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004058175A2 (en) * 2002-12-23 2004-07-15 Irm Llc Novel use of liver x receptor agonists
WO2006077012A2 (en) * 2005-01-18 2006-07-27 Genfit S.A. USE OF LXR LIGANDS FOR THE MODULATION OF DENDRITIC CELLS (DCs)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7101681B1 (en) * 1997-11-21 2006-09-05 Amgen, Inc. Nuclear hormone receptor drug screens
US6316503B1 (en) * 1999-03-15 2001-11-13 Tularik Inc. LXR modulators
JP2004500332A (en) * 1999-07-08 2004-01-08 テュラリク　インコーポレイテッド Compositions and methods for increasing HDL cholesterol levels
AU7115300A (en) * 1999-09-08 2001-04-10 Glaxo Group Limited Oxazole ppar antagonists
CA2392568A1 (en) * 1999-12-13 2001-06-14 Merck & Co., Inc. Method for the prevention and/or treatment of atherosclerosis
AU2000235960A1 (en) * 2000-02-14 2001-08-27 Tularik, Inc. Lxr modulators
US6673543B2 (en) * 2000-04-05 2004-01-06 Tularik, Inc. Solid phase synthesis of LXR ligands
AU2001262984A1 (en) * 2000-05-03 2001-11-12 Tularik, Inc. Treatment of hypertriglyceridemia and other conditions using lxr modulators
JP2004507232A (en) * 2000-06-13 2004-03-11 ザ・ボード・オブ・トラステイーズ・フオー・ザ・ユニバーシテイ・オブ・アーカンソー Methods for separating non-nuclear regulatory-mediated activity from steroid receptor-mediated nuclear transcription-regulating activity
GB0019290D0 (en) * 2000-08-04 2000-09-27 Symphar Sa Methods for inducing apolipoprotein E secretion

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023240376A1 (en) * 2022-06-12 2023-12-21 中国医学科学院药物研究所 Use of intestinal epithelial cell nuclear receptor repressor ncor as target in drug screening

Also Published As

Publication number Publication date
GB2381866A (en) 2003-05-14

Similar Documents

Publication Publication Date Title
HUP0303809A3 (en) Assay system
GB0120126D0 (en) Assay device
EP1442299A4 (en) Assay
EP1470421A4 (en) Rapid prion-detection assay
GB0115777D0 (en) Assay
GB0012860D0 (en) Assay
PL370539A1 (en) Assay
GB0008784D0 (en) Assay
GB0101313D0 (en) Assay
GB0120589D0 (en) Assay
GB0121440D0 (en) Assay
GB0005894D0 (en) Assay
GB0003902D0 (en) Assay
GB0127132D0 (en) Assay
GB0010960D0 (en) Assay
GB0200428D0 (en) Assay
GB0101312D0 (en) Assay
GB0025804D0 (en) Assay
GB0001703D0 (en) Assay
GB0105362D0 (en) Assay
GB0100290D0 (en) Assay
GB0013561D0 (en) Assay
GB0019242D0 (en) Assay
GB0003898D0 (en) Assay
GB0023239D0 (en) Assay

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)